By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Dicerna Pharmaceuticals 

480 Arsenal Street
Building 1, Suite 120
Watertown  Massachusetts  02472  U.S.A.
Phone: 617-621-8097 Fax: n/a


Start Up

Company News
Dicerna Pharmaceuticals (DRNA) Presents Positive Preclinical Data On Its DsiRNA Therapeutics Targeting MYC And ?-Catenin At American Association for Cancer Research MYC: From Biology To Therapy Meeting 1/12/2015 12:53:51 PM
Dicerna Pharmaceuticals (DRNA) Announces Issuance Of US Patent Providing Broad Coverage Of DsiRNA-EX RNAi Payloads 1/12/2015 12:47:47 PM
Dicerna Pharmaceuticals (DRNA) Announces The Appointment Of Theodore T. Ashburn, M.D., Ph.D. To Senior Vice President, Product Strategy And Operations, And Inducement Grant Of Stock Options Under NASDAQ Listing Rule 5635 (C)(4) 12/18/2014 9:23:33 AM
Dicerna Pharmaceuticals (DRNA) R&D Update Webcast Reminder 12/15/2014 8:38:00 AM
Dicerna Pharmaceuticals (DRNA) To Present At The 2014 Deutsche Bank (DB) BioFEST 11/25/2014 10:58:43 AM
Dicerna Pharmaceuticals (DRNA) Reports On Progress Of Development Programs 11/17/2014 5:15:14 PM
Dicerna Pharmaceuticals (DRNA) To Present At Two Upcoming Investor Conferences 11/17/2014 4:49:17 PM
Tekmira (TKMR) Announces $24.5M Licensing And Collaboration Agreement With Dicerna Pharmaceuticals (DRNA) 11/17/2014 6:42:47 AM
Dicerna Pharmaceuticals (DRNA) Announces Third Quarter 2014 Financial And Operational Results 11/6/2014 11:14:31 AM
Dicerna Pharmaceuticals (DRNA) To Announce Third-Quarter 2014 Financial Results And Host Conference Call On November 6, 2014 10/27/2014 8:52:00 AM